BNP Paribas Financial Markets
HCAT icon

BNP Paribas Financial Markets’s Health Catalyst HCAT Stock Holding History

BNP Paribas Financial Markets’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05K Sell
3,545
-26,191
-88% -$37.8K ﹤0.01% 5423
2026
Q1 		$37.8K Buy
29,736
+12,074
+68% +$22.7K ﹤0.01% 4841
2025
Q4 		$42.2K Buy
17,662
+1,307
+8% +$3.57K ﹤0.01% 4761
2025
Q3 		$46.6K Buy
16,355
+6,832
+72% +$23.4K ﹤0.01% 4624
2025
Q2 		$35.9K Sell
9,523
-104,222
-92% -$410K ﹤0.01% 4372
2025
Q1 		$515K Buy
113,745
+9,744
+9% +$51.6K ﹤0.01% 3167
2024
Q4 		$735K Buy
+104,001
New +$828K ﹤0.01% 3032

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

BNP Paribas Financial Markets's HCAT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Health Catalyst (HCAT) stake by 88% in Q2 2026, selling an estimated $37.8K and leaving 3,545 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #5423.

BNP Paribas Financial Markets first reported a position in HCAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $735K in Q4 2024. 119 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • BNP Paribas Financial Markets held 3,545 shares of Health Catalyst worth $7.05K as of Q2 2026.
  • BNP Paribas Financial Markets sold 26,191 Health Catalyst shares in Q2 2026, an estimated $37.8K.
  • Health Catalyst made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5423 holding.
  • BNP Paribas Financial Markets first reported a position in Health Catalyst in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Health Catalyst position peaked at $735K in Q4 2024.
  • 119 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.